24 January 2020

Rick Wansink (Dept. of Cell Biology) and Roland Brock (Dept. of Biochemistry), both theme Nanomedicine, received a €280,000 grant from the Prinses Beatrix Spierfonds. They will investigate to which degree the required antisense oligonucleotide concentration to correct the defect in myotonic dystrophy depends on the severity of the disease.

In addition, novel methods for targeted delivery will be developed. The results will be crucial for the clinical implementation of oligonucleotide-based therapies.

Related news items

'Stofwisselkracht' grant for Paola de Haas and Alessandra Cambi

5 December 2019 Paola de Haas and Alessandra Cambi, theme Nanomedicine, have recently been awarded a grant from ‘Stichting Stofwisselkracht’ for their project entitled “Identification of immune-related symptoms in Congenital Disorders of Glycosylation”. read more

Podosome nanoscale architecture redefined

20 November 2019 Koen van den Dries and Alessandra Cambi, theme Nanomedicine, revealed how the nanoscale architecture of podosomes enables dendritic cells to protrude and sense their extracellular environment. They have published their results in Nature Communications. read more

MMD Lecturer of the year award for Alessandra Cambi

16 September 2019 At their annual MMD symposium, Alessandra Cambi, theme Nanomedicine, was chosen as lecturer of the year 2018-2019 of the Top Master "Molecular mechanisms of disease".  read more

RIMLS PhD grants awarded to eight RIMLS (j)PI's

12 September 2019 Recently, RIMLS held an internal call for Radboudumc junior researcher (PhD) positions. Congratulations for all the awardees and all the best in conducting the research projects. read more

TURBO grants for four medical-technical research projects

8 November 2018 Four TURBO grants were awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between Radboudumc and the University of Twente. read more